Fourth COVID vaccine manufacturer seeking FDA approval

Published November 8, 2021 6:42 AM

(KYMA, KECY) - Another company hopes to offer its version of a coronavirus vaccine in the months ahead.

Novavax plans to turn-in complete data to the U.S. Food and Drug Administration (FDA) before the end of the year.

Its aim would be to earn possible emergency use authorization for its vaccine.

The biotech company's CEO says a first 100 million doses would be ready to ship if an FDA green light is given.

Novavax says it's vaccine manufacturing method is more conventional than those vaccines currently authorized for use in the U.S.

This version stimulates immunity by using small laboratory-made pieces of the coronavirus.

Article Topic Follows: Top Stories

Jump to comments ↓

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.